Keymed Biosciences

News

Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.

News

Spyre Therapeutics’ hopes for its anti-TL1A antibody SPY072 in rheumatoid arthritis (RA) have hit a bump in the road.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.